Puplava Financial Services Inc. Has $525,000 Position in CME Group Inc. (CME)
Puplava Financial Services Inc. maintained its stake in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,190 shares of the financial services provider’s stock at the end of the second quarter. Puplava Financial Services Inc.’s holdings in CME Group were worth $525,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. First Citizens Bank & Trust Co. boosted its position in shares of CME Group by 141.3% in the second quarter. First Citizens Bank & Trust Co. now owns 19,990 shares of the financial services provider’s stock valued at $2,504,000 after buying an additional 11,707 shares during the last quarter. Quantitative Systematic Strategies LLC acquired a new stake in shares of CME Group during the second quarter worth about $1,333,000. Huntington National Bank raised its stake in shares of CME Group by 60.6% in the second quarter. Huntington National Bank now owns 1,367 shares of the financial services provider’s stock worth $171,000 after buying an additional 516 shares during the period. Private Bank & Trust Co. raised its stake in shares of CME Group by 51.5% in the second quarter. Private Bank & Trust Co. now owns 5,000 shares of the financial services provider’s stock worth $626,000 after buying an additional 1,700 shares during the period. Finally, Financial Architects Inc raised its stake in shares of CME Group by 6.3% in the second quarter. Financial Architects Inc now owns 2,035 shares of the financial services provider’s stock worth $255,000 after buying an additional 120 shares during the period. 83.09% of the stock is owned by institutional investors.
Shares of CME Group Inc. (NASDAQ CME) traded up 0.718% during mid-day trading on Wednesday, hitting $122.765. The stock had a trading volume of 377,741 shares. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96. The firm’s 50-day moving average price is $123.55 and its 200 day moving average price is $120.32. The stock has a market cap of $41.71 billion, a price-to-earnings ratio of 26.573 and a beta of 0.74.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.02. The firm had revenue of $929 million for the quarter, compared to analyst estimates of $932.06 million. CME Group had a return on equity of 7.43% and a net margin of 43.62%. The business’s quarterly revenue was down .5% compared to the same quarter last year. During the same period last year, the company earned $1.15 EPS. Equities analysts forecast that CME Group Inc. will post $4.86 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 26th. Shareholders of record on Friday, June 9th were given a $0.66 dividend. The ex-dividend date was Wednesday, June 7th. This represents a $2.64 dividend on an annualized basis and a yield of 2.17%. CME Group’s payout ratio is 57.14%.
CME has been the topic of a number of recent research reports. Deutsche Bank AG cut their target price on shares of CME Group from $137.00 to $134.00 and set a “buy” rating on the stock in a research note on Friday, April 28th. Royal Bank Of Canada decreased their price objective on CME Group from $133.00 to $130.00 and set an “outperform” rating for the company in a report on Monday, May 1st. Jefferies Group LLC reaffirmed a “buy” rating and set a $134.00 price target (up from $128.00) on shares of CME Group in a report on Monday, July 17th. Finally, BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. CME Group currently has a consensus rating of “Hold” and a consensus target price of $128.00.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction on Monday, July 10th. The stock was sold at an average price of $124.50, for a total value of $311,250.00. Following the transaction, the chief financial officer now directly owns 38,495 shares in the company, valued at approximately $4,792,627.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Kathleen M. Cronin sold 8,125 shares of the firm’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now owns 38,174 shares in the company, valued at $4,861,458.90. The disclosure for this sale can be found here. Insiders sold a total of 48,754 shares of company stock worth $5,955,724 over the last quarter. Corporate insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.